CN102435732A - Toxoplasma IgM antibody immunoblotting kit and preparation method thereof - Google Patents
Toxoplasma IgM antibody immunoblotting kit and preparation method thereof Download PDFInfo
- Publication number
- CN102435732A CN102435732A CN2011102793146A CN201110279314A CN102435732A CN 102435732 A CN102435732 A CN 102435732A CN 2011102793146 A CN2011102793146 A CN 2011102793146A CN 201110279314 A CN201110279314 A CN 201110279314A CN 102435732 A CN102435732 A CN 102435732A
- Authority
- CN
- China
- Prior art keywords
- igm antibody
- antibody
- toxoplasma
- toxoplasma gondi
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
The invention which relates to a kit concretely relates to a toxoplasma IgM antibody immunoblotting kit and a preparation method thereof. The kit is characterized in that: the kit is provided with a vector plate, a nitrocellulose film, a toxoplasma IgM antibody detection line and a contrast line; the toxoplasma IgM antibody detection line and the contrast line are sequentially arranged on the nitrocellulose film; the toxoplasma IgM antibody detection line is coated with a toxoplasma recombinant antigen, and the contrast line is coated with a human IgM antibody; and an anti-human mum-chain antibody is labeled with horseradish peroxidase. The preparation method comprises the following steps: 1, preparing the toxoplasma antigen; 2, carrying out nitrocellulose film spotting; 3, preparing an anti-human IgM specific fragment mum-chain monoclonal antibody; 4, labeling the anti-human IgM specific fragment mum-chain monoclonal antibody with the horseradish peroxidase; and 5, preparing the immunoblotting kit. The kit of the invention, which allows the needed sample amount to be extremely small and no special instrument to be needed during detection and allows the result to be directly interpreted by naked eyes, has the advantages of simple and rapid detection, strong specificity, high sensitivity, accuracy and reliability, low cost, and wide application.
Description
Technical field
The present invention relates to a kind of kit, especially relate to a kind of Toxoplasma Gondi IgM antibody and detect HP immunoblotting kit and preparation method thereof.
Background technology
Toxoplasmosis (Toxoplasmosis) is that the people beast of a kind of serious harm human health of causing of toxoplasma gondii (Toxoplasmagondii) suffers from parasitic disease altogether; The arc worm of its pathogen can colonize in the karyocyte of people and multiple animal, the general susceptible of crowd and animal.This disease is distributed widely in all over the world, according to statistics the whole world have approximately 1,000,000,000 people by arch insect infection ([1] Xi Linlin, Li Wei. arc worm pathogenesis, virulence and genotype progress [J]. Chinese Pathogen Biology magazine, 2009,4 (11): 859-861).Toxoplasmosis distributes very extensive in China; All there are the report of arch insect infection in each province, the whole nation, city, autonomous region; The average infection rate of China's normal population about 4%～9% ([2] Liu Min, Chen Xiaoguang. the analysis on epidemic of Chinese population toxoplasmosis [J]. parasite and medical insect journal, 2010; 17 (3): 131-134), special population such as tumor patient, mental patient, birth defect infant, immunosupress, immunodeficiency patient infection lead higher.Normal adult of thumping majority immunologic function or children are normal asymptomatic or light symptoms is only arranged after by arch insect infection fortunately, and multipotency self-healing and obtain permanent immunity.But after the fetus of congenital infection, children and immunodeficiency person were infected, then prognosis was very serious.It is an important intercurrent disease that causes the AIDS patient dead.Human immunodeficiency virus (HIV) the infected has 20%～80% to merge arch insect infection approximately, the more important thing is that it also is one of important pathogen that causes human congenital malformation, defective, feeblemindedness, stillborn foetus, premature labor.
The diagnostic method of existing toxoplasmosis comprises directly and carries out etiological diagnosis from arc worms of separate tissue such as internal organs, blood, cerebrospinal fluid, needs several days even a few time-of-week, wastes time and energy, and in practical application, is worth little.Conventional sense mainly is to use various serological methods clinically; Detect its special IgG and IgM ([3] Zhou Bin, Zhang Jue, Wang Ke; Deng. the foundation and the Preliminary Clinical [J] thereof of Toxoplasma Gondi IgG and IgM antibody double-tagging time resolved fluoro-immunoassay. Chinese laboratory medicine magazine; 2010,33 (010): 957-959.), serological method can Diagnosis of Congenital, acute and chronic toxoplasmosis; But because the IgG titre of its resisting toxoplasmosis of human or animal of most of immunodeficiencies can not rise or high IgM titre can not occur, so can not diagnose toxoplasmosis with serological method to the human or animal who suffers from immunodeficiency effectively.In addition, serum antibody titer just can progressively descend after antigen disappears the long duration, so can not be applied to treatment effectiveness evaluation.Detect IgG antibody at present and have higher false positive, and problems such as the general poor sensitivity of IgM antibody test ([4] Han Jingyun, Liu Qian, Guo Jian. the technical progress of arch insect infection laboratory diagnosis [J]. laboratory medicine, 2009,24 (5): 393-395.).Therefore, the early diagnosis of disease is helped little, is badly in need of setting up a kind of high susceptibility that has, and inexpensive, quick, simple to operate, do not need specific installation, be more suitable in clinical method of early diagnosis.
The diagnosis of toxoplasmosis and epidemiology survey mainly depend on serological test; Mostly normal human's toxoplasma gondii infection is subclinical infection; When immunity of organisms descended, polypide bred in a large number, invaded and removed exo-erythrocytic each histocyte endoparasitism; Cause the extensive inflammation of various tissues, thereby clinical symptoms occurs.Can inducing producing specificity antibody behind the arc worm of human infection.Infecting early stage IgM antibody increases; IgM fades away after infecting 4 months; High concentration IgG antibody ([5] KASPER D C appears after infecting 1 month; PRUSA A R, HAYDE M, et al.Evaluation of the vitros eciq immunodiagnostic system for detection of anti-toxoplasma immunoglobulin g and immunoglobulin m antibodies for confirmatory testing for acute toxoplasma gondii infection in pregnant women [J] .Journal of clinical microbiology; 2009,47 (1): 164-168.).Therefore, Toxoplasma Gondi IgG antibody is an important indicator of toxoplasmosis diagnosis and epidemiology survey.
Early stage serological method uses arch insect circulating antigen.The arch insect circulating antigen of research and diagnosis usefulness is to obtain with the arch insect infection mouse peritoneal, antigen amount few and impure (often being mixed with host protein) big, that obtain that this method spends, so false positive also happens occasionally.Along with the clone in succession who reaches toxoplasma antigen that popularizes of Protocols in Molecular Biology, it is more and more that recombinant antigen is applied to arc worm experiment.Surface antigen (SAG1 (P30), SAG2 (P22), SAG3 (P43), SAG4 (P18)), polypide clava antigen (ROP1, ROP2), dense granule albumen ([6] Xiong Meihua such as (GRA1, GRA7) of the arc worm that research at present is many; Wang Xiuzhen; Liu Luxia; Deng. the extraction of toxoplasma tachyzoite antigen and analysis of protein [J]. Chinese preventing and treating verminosis magazine, 2001,14 (3): 237-238.).The recombinant antigen that adopts recombinant DNA technology to prepare can overcome the shortcoming of complete toxoplasma antigen, can prepare endless special recombinant toxoplasma antigen fast, economically.
Existing toxoplasma antibody detection method comprises ELISA, Western-blot etc., and its specificity is all higher.The kit that adopts the Western-blot method to process, general Routine Test Lab all can be accomplished, and does not need specific installation, and interpretation is also simple and clear.Existing commercially available Western-blot reagent is import reagent, costs an arm and a leg.In the face of severe anti-system form, not only need special detection means accurately, also need a kind of reagent of more economical practicality to come examination, so that with the disease prevention and control countermeasure is provided for clinical.
Summary of the invention
The purpose of this invention is to provide a kind of Toxoplasma Gondi IgM antibody HP immunoblotting kit and preparation method thereof.
Said Toxoplasma Gondi IgM antibody HP immunoblotting kit is provided with carrier board, nitrocellulose membrane, Toxoplasma Gondi IgM antibody detection line and control line; Said Toxoplasma Gondi IgM antibody detection line and control line are located on the nitrocellulose membrane successively; Encapsulate arc worm recombinant antigen at Toxoplasma Gondi IgM antibody detection line place, the place encapsulates human IgM antibody at control line; The anti-people μ of horseradish peroxidase-labeled chain antibody.
Said arc worm recombinant antigen is SAG1 (P30), SAG2 (P22), ROP2, GRA7 recombinant antigen.
Said carrier board can adopt the PVC plate.
The preparation method of said Toxoplasma Gondi IgM antibody HP immunoblotting kit may further comprise the steps:
1) the arc worm recombinant antigen of preparation
Adopt gene clone technology, the DNA of pcr amplification coding toxoplasma antigen, and make its expression in the insertion Escherichia coli, get arc worm recombinant antigen;
2) point sample of nitrocellulose filter
On nitrocellulose filter IgM detection line, encapsulate arc worm recombinant antigen, the place encapsulates human IgM antibody at control line, dries;
3) the anti-people IgM specific fragment μ chain monoclonal antibody of preparation
With people IgM specific fragment μ chain is antigen immune Balb/c mouse, and through hybridoma technology, screening obtains the hybridoma cell strain of the anti-people IgM of stably excreting monoclonal antibody;
4) horseradish peroxidase (HRP) mark of anti-people IgM specific fragment μ chain monoclonal antibody
Adopt the sodium periodate method to carry out horseradish peroxidase (HRP) mark;
5) preparation HP immunoblotting kit
Nitrocellulose membrane is sticked on the carrier board upper surface; Toxoplasma Gondi IgM antibody detection line and control line are located on the nitrocellulose membrane successively; Encapsulate arc worm recombinant antigen at Toxoplasma Gondi IgM antibody detection line place; The place encapsulates human IgM antibody at control line, is cut into strip with cutting cutter, dresses up the Toxoplasma Gondi IgM antibody HP immunoblotting kit with the anti-people μ chain monoclonal antibody and the substrate mutual group thereof of enzyme labeling.
In step 1), 2), 5) in, said arc worm recombinant antigen is SAG1 (P30), SAG2 (P22), ROP2, GRA7 etc.
In step 2) in, the concentration of said arc worm recombinant antigen and human IgM antibody can be 1～4mg/mL; The point sample amount can be 1 μ L/cm.
In step 3), adopt the method identification of M cAb of ELISA to tire at 1: 10
7More than.
In step 4), the substrate of said horseradish peroxidase is made up of the diaminobenzidine of the hydrogen peroxide and 0.07% (W/V) of 0.03% (W/V).
The invention provides a kind of employing immunoblot assay and set up the toxoplasmosis IgM antigen testing reagent bar, can be used for the detection of Toxoplasma Gondi IgM antibody in the samples such as whole blood, serum, blood plasma and cerebrospinal fluid.The required specimen amount of this detection method is minimum, does not need specific apparatus, the direct sentence read result of naked eyes, and detect easy fast, high specificity, highly sensitive, accurately and reliably, cost is low, is widely used.
Description of drawings
Fig. 1 is that the structure of film bar embodiment in the Toxoplasma Gondi IgM antibody HP immunoblotting kit according to the invention is formed synoptic diagram.
Fig. 2 is the experimental result pattern diagram.In Fig. 2, H is the synoptic diagram before using, and G is invalid test (product quality problem), the negative result of F, and A～E is the Toxoplasma Gondi IgM positive findings; 2 is arc worm SAG1 (P30)-IgM antibody detection line, and 3 is arc worm SAG2 (P22)-IgM antibody detection line, and 4 is arc worm ROP2-IgM antibody detection line, and 5 is arc worm GRA7-IgM antibody detection line, and 6 is control line.
Embodiment
Following examples will combine accompanying drawing that the present invention is further described.
Referring to Fig. 1, Toxoplasma Gondi IgM antibody HP immunoblotting kit embodiment according to the invention is provided with carrier board 1, Toxoplasma Gondi IgM antibody detection line 2～5, control line 6 and nitrocellulose membrane (NC film) 7.
Nitrocellulose membrane 7 sticks on carrier board 1 upper surface, and Toxoplasma Gondi IgM antibody detection line 2～5 is located on the nitrocellulose membrane 7 with control line 6 successively; Encapsulate arc worm recombinant antigen SAG1 (P30), SAG2 (P22), ROP2 and GRA7 respectively at Toxoplasma Gondi IgM antibody detection line place, 6 places encapsulate human IgM antibody at control line.
Said carrier board adopts the PVC plate.
The preparation method of said Toxoplasma Gondi IgM antibody HP immunoblotting kit may further comprise the steps:
1) preparation SAG1 (P30), SAG2 (P22), ROP2 and the arc worm recombinant antigen of GRA7
Adopt gene clone technology, the pcr amplification DNA of arc worm leptospira antigen that encodes, and insert in the Escherichia coli and make its expression, arc worm recombinant antigen SAG1 (P30), SAG2 (P22), ROP2 and GRA7.
2) point sample of nitrocellulose filter
On nitrocellulose filter IgM detection line, encapsulate SAG1 (P30), SAG2 (P22), ROP2 and the arc worm recombinant antigen of GRA7, the place encapsulates human IgM antibody at control line, dries.
3) the anti-people IgM specific fragment μ chain monoclonal antibody of preparation
With people IgM specific fragment μ chain is antigen immune Balb/c mouse, and through hybridoma technology, screening obtains the hybridoma cell strain of the anti-people IgM of stably excreting monoclonal antibody.Adopt the method identification of M cAb of ELISA to tire at 1: 10
7More than.
4) horseradish peroxidase (HRP) mark of anti-people IgM specific fragment μ chain monoclonal antibody
Adopt the sodium periodate method to carry out horseradish peroxidase (HRP) mark.
5) preparation HP immunoblotting kit
Nitrocellulose membrane is sticked on the carrier board upper surface, and Toxoplasma Gondi IgM antibody detection line and control line are located on the nitrocellulose membrane successively; Encapsulate arc worm recombinant antigen SAG1 (P30), SAG2 (P22), ROP2 and GRA7 at Toxoplasma Gondi IgM antibody detection line place; The place encapsulates human IgM antibody at control line; The anti-people μ chain monoclonal antibody and the substrate mutual group thereof that are cut into strip and enzyme labeling with cutting cutter are dressed up the Toxoplasma Gondi IgM antibody HP immunoblotting kit.
Below provide the clinical samples that adopts the Toxoplasma Gondi IgM antibody HP immunoblotting kit to detect the patient:
1) sample adopts the 0.01mol/LPBS damping fluid to carry out dilution in 1: 50.
2) sealing: adopt 5% skimmed milk power (preparation of 0.01mol/L PBST damping fluid), waving incubation 30min on the shaking table in room temperature (18～25 ℃) as confining liquid.
3) serum incubation: take out required film bar, put it in the incubation groove, and numbering.In the incubation groove, add 1.5ml diluted sample respectively.Waving incubation 30min on the shaking table in room temperature (18～25 ℃).
4) clean: inhale and remove liquid in the groove, waving on the shaking table with 1.5ml 0.01mol/L PBS buffer solution for cleaning film bar 3 times, at every turn 5min.
5) add enzyme conjugates: in the incubation groove, add the enzyme conjugates (the anti-people IgM specific fragment μ chain monoclonal antibody that adopts horseradish peroxidase-labeled is for detecting antibody) that 1.5ml has diluted, waving incubation 30min on the shaking table in room temperature (18～25 ℃).
6) clean: inhale and remove liquid in the groove, waving on the shaking table with 1.5ml 0.01mol/L PBS buffer solution for cleaning film bar 3 times, at every turn 5min.
7) substrate incubation: in the incubation groove, add 1.5ml substrate solution (DAB) respectively, waving incubation 10min on the shaking table in room temperature (18～25 ℃).
8) stop: inhale and remove liquid in the groove, clean the film bar 3 times, each 1min with distilled water.
The result judges: will detect the film bar and be placed on the result and judge in the template air-dry judged result afterwards.Any protein targets marks existing specific band, all can be judged as the positive, but auxiliary diagnosis toxoplasmosis (see figure 2).
Below provide the performance calibrating of Toxoplasma Gondi IgM antibody HP immunoblotting kit:
1) visual examination: kit does not have breakage, encapsulates smooth, the clean pollution-free spot of reaction film, free from flaw, and adhesive tape does not have and comes unglued, and does not have and cuts oblique phenomenon.
2) positive sample coincidence rate: the positive control serum with the positive different titers of Toxoplasma Gondi IgM adopts the calibrating of Toxoplasma Gondi IgM antibody HP immunoblotting kit for each 50 parts, calculates positive coincidence rate.The clinical samples that definite employing ELISA (import reagent) method of positive control serum is confirmed.
3) negative sample coincidence rate:, calculate negative match-rate with 50 parts of negative control serum calibratings.The clinical samples that definite employing ELISA (import reagent) method of negative control serum is confirmed.
4) criticize interior difference: same batch of Toxoplasma Gondi IgM antibody HP immunoblotting kit, detect with characteristic serum, require the positive serum testing result to show that the shade of colour band is consistent, result's feminine gender that negative serum detects.
5) differences between batches: different batches Toxoplasma Gondi IgM antibody HP immunoblotting kit, detect with characteristic serum, require the positive serum testing result to show that the shade of colour band is consistent, the result that negative serum detects is negative.
6) interference test: testing result does not receive the interference of sample hemolysis (n=50), piarhemia (n=50) and jaundice (n=50).
7) cross reaction: adopt this Toxoplasma Gondi IgM antibody HP immunoblotting kit, carry out the detection of systemic loupus erythematosus (n=30), rheumatoid disease (n=30), autoallergic autoimmunity systemic diseases such as (n=30), do not find cross reaction.
8) Detection of Stability: use the Arrhenius rule, the Toxoplasma Gondi IgM antibody HP immunoblotting kit is placed 37 ℃ detect after 20 days, above each item index does not have marked change, guarantees that finished product preserves under the drying at room temperature condition, and the term of validity is 18 months.
Below provide specific embodiment.
Embodiment 1
Nitrocellulose membrane is sticked on the carrier board upper surface, and Toxoplasma Gondi IgM antibody detection line and control line are located on the nitrocellulose membrane successively; Encapsulate arc worm recombinant antigen SAG1 (P30), SAG2 (P22), ROP2 and GRA7 at Toxoplasma Gondi IgM antibody detection line place; The place encapsulates human IgM antibody at control line; The anti-people μ chain monoclonal antibody and the substrate mutual group thereof that are cut into strip and enzyme labeling with cutting cutter are dressed up the Toxoplasma Gondi IgM antibody HP immunoblotting kit.
1) sample adopts the 0.01mol/LPBS damping fluid to carry out dilution in 1: 50.
2) sealing: adopt 5% skimmed milk power (preparation of 0.01mol/L PBST damping fluid), waving incubation 30min on the shaking table in room temperature (18～25 ℃) as confining liquid.
3) serum incubation: take out required film bar, put it in the incubation groove, and numbering.In the incubation groove, add 1.5ml diluted sample respectively.Waving incubation 30min on the shaking table in room temperature (18～25 ℃).
4) clean: inhale and remove liquid in the groove, waving on the shaking table with 1.5ml 0.01mol/L PBS buffer solution for cleaning film bar 3 times, at every turn 5min.
5) add enzyme conjugates: in the incubation groove, add the enzyme conjugates (the anti-people IgM specific fragment μ chain monoclonal antibody that adopts horseradish peroxidase-labeled is for detecting antibody) that 1.5ml has diluted, waving incubation 30min on the shaking table in room temperature (18～25 ℃).
6) clean: inhale and remove liquid in the groove, waving on the shaking table with 1.5ml 0.01mol/L PBS buffer solution for cleaning film bar 3 times, at every turn 5min.
7) substrate incubation: in the incubation groove, add 1.5ml substrate solution (DAB) respectively, waving incubation 10min on the shaking table in room temperature (18～25 ℃).
8) stop: inhale and remove liquid in the groove, clean the film bar 3 times, each 1min with distilled water.
The result judges: will detect the film bar and be placed on the result and judge in the template air-dry judged result afterwards.Any protein targets marks existing specific band, all can be judged as the positive, but auxiliary diagnosis toxoplasmosis (see figure 2).
Similar with embodiment 1, its difference is that the nitrocellulose membrane detection line only is made up of the arc worm recombinant antigen of SAG2 (P22), ROP2 and GRA7, does not contain the arc worm recombinant antigen of SAG1 (P30).The result judges identical with embodiment 1.
Similar with embodiment 1, its difference is that the nitrocellulose membrane detection line only is made up of the arc worm recombinant antigen of SAG1 (P30), ROP2 and GRA7, does not contain the arc worm recombinant antigen of SAG2 (P22).The result judges identical with embodiment 1.
Similar with embodiment 1, its difference is that the nitrocellulose membrane detection line only is made up of SAG1 (P30), SAG2 (P22) and GRA7 recombinant antigen, does not contain the ROP2 recombinant antigen.The result judges identical with embodiment 1.
Similar with embodiment 1, its difference is that the nitrocellulose membrane detection line only is made up of SAG1 (P30), SAG2 (P22) and the arc worm recombinant antigen of ROP2, does not contain the arc worm recombinant antigen of GRA7.The result judges identical with embodiment 1.
Similar with embodiment 1, its difference is that sample to be checked is a samples of CSF, and the result judges identical with embodiment 1.
Embodiment 7
Performance verification test: prepare the Toxoplasma Gondi IgM antibody HP immunoblotting kit by embodiment 1 scheme, carry out performance verification again.
1) visual examination: kit does not have breakage, encapsulates smooth, the clean pollution-free spot of reaction film, free from flaw, and adhesive tape does not have and comes unglued, and does not have and cuts oblique phenomenon.
2) positive sample coincidence rate: the positive reference sample with the positive different titers of Toxoplasma Gondi IgM adopts the calibrating of Toxoplasma Gondi IgM antibody HP immunoblotting kit for each 50 parts, calculates positive coincidence rate.The clinical samples that definite employing ELISA (advancing article reagent) method of positive reference sample is confirmed.
3) negative sample coincidence rate:, calculate negative match-rate with 50 parts of negative reference sample calibratings.The clinical samples that definite employing ELISA (advancing article reagent) method of negative reference sample is confirmed.
4) criticize interior difference: same batch of Toxoplasma Gondi IgM antibody HP immunoblotting kit, detect with the characteristic sample, require the positive sample testing result to show that the shade of colour band is consistent, result's feminine gender that negative sample detects.
5) differences between batches: different batches Toxoplasma Gondi IgM antibody HP immunoblotting kit, detect with the characteristic sample, require the positive sample testing result to show that the shade of colour band is consistent, the result that negative sample detects is negative.
6) cross reaction: adopt this Toxoplasma Gondi IgM antibody HP immunoblotting kit, carry out the detection of systemic loupus erythematosus (n=30), rheumatoid disease (n=30), autoallergic autoimmunity systemic diseases such as (n=30), do not find cross reaction.
7) Detection of Stability: use the Arrhenius rule, the Toxoplasma Gondi IgM antibody HP immunoblotting kit is placed 37 ℃ detect after 20 days, above each item index does not have marked change, guarantees that finished product preserves under the drying at room temperature condition, and the term of validity is 18 months.
Claims (8)
1. the Toxoplasma Gondi IgM antibody HP immunoblotting kit is characterized in that being provided with carrier board, nitrocellulose membrane, Toxoplasma Gondi IgM antibody detection line, control line, and Toxoplasma Gondi IgM antibody detection line and control line are located on the nitrocellulose membrane successively; Encapsulate arc worm recombinant antigen at Toxoplasma Gondi IgM antibody detection line place, the place encapsulates human IgM antibody at control line; The anti-people μ of horseradish peroxidase-labeled chain antibody.
2. Toxoplasma Gondi IgM antibody HP immunoblotting kit as claimed in claim 1 is characterized in that said arc worm recombinant antigen is SAG1 (P30), SAG2 (P22), ROP2, GRA7, but is not limited to above antigen.
3. Toxoplasma Gondi IgM antibody HP immunoblotting kit as claimed in claim 1 is characterized in that said carrier board adopts the PVC plate.
4. the preparation method of Toxoplasma Gondi IgM antibody HP immunoblotting kit as claimed in claim 1 is characterized in that may further comprise the steps:
1) the arc worm recombinant antigen of preparation
Adopt gene clone technology, the pcr amplification DNA of arc worm leptospira antigen that encodes, and insert in the Escherichia coli and make its expression, arc worm recombinant antigen;
2) point sample of nitrocellulose filter
On nitrocellulose filter IgM detection line, encapsulate arc worm recombinant antigen, the place encapsulates human IgM antibody at control line, dries;
3) the anti-people IgM specific fragment μ chain monoclonal antibody of preparation
With people IgM specific fragment μ chain is antigen immune Balb/c mouse, and through hybridoma technology, screening obtains the hybridoma cell strain of the anti-people IgM of stably excreting monoclonal antibody;
4) horseradish peroxidase-labeled of anti-people IgM specific fragment μ chain monoclonal antibody
Adopt the sodium periodate method to carry out horseradish peroxidase-labeled;
5) preparation HP immunoblotting kit
Nitrocellulose membrane is sticked on the carrier board upper surface; Toxoplasma Gondi IgM antibody detection line and control line are located on the nitrocellulose membrane successively; Encapsulate arc worm recombinant antigen at Toxoplasma Gondi IgM antibody detection line place; The place encapsulates human IgM antibody at control line, is cut into strip with cutting cutter, dresses up the Toxoplasma Gondi IgM antibody HP immunoblotting kit with the anti-people μ chain monoclonal antibody and the substrate mutual group thereof of enzyme labeling.
5. the preparation method of Toxoplasma Gondi IgM antibody HP immunoblotting kit as claimed in claim 4 is characterized in that in step 1), and said arc worm recombinant antigen is SAG1 (P30), SAG2 (P22), ROP2, GRA7.
6. the preparation method of Toxoplasma Gondi IgM antibody HP immunoblotting kit as claimed in claim 4 is characterized in that in step 2) in, the concentration of said arc worm recombinant antigen and human IgM antibody is 1～4mg/mL; The point sample amount is 1 μ L/cm.
7. the preparation method of Toxoplasma Gondi IgM antibody HP immunoblotting kit as claimed in claim 4 is characterized in that in step 3), adopts the method identification of M cAb of ELISA to tire more than 1: 107.
8. the preparation method of Toxoplasma Gondi IgM antibody HP immunoblotting kit as claimed in claim 4; It is characterized in that in step 4) the substrate of said horseradish peroxidase is made up of 0.03% hydrogen peroxide and 0.07% diaminobenzidine by mass/volume number percent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102793146A CN102435732A (en) | 2011-09-19 | 2011-09-19 | Toxoplasma IgM antibody immunoblotting kit and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102793146A CN102435732A (en) | 2011-09-19 | 2011-09-19 | Toxoplasma IgM antibody immunoblotting kit and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102435732A true CN102435732A (en) | 2012-05-02 |
Family
ID=45983895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102793146A Pending CN102435732A (en) | 2011-09-19 | 2011-09-19 | Toxoplasma IgM antibody immunoblotting kit and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102435732A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108330104A (en) * | 2018-03-30 | 2018-07-27 | 四川迈克生物新材料技术有限公司 | Anti-human IgM monoclonal antibody, its hybridoma cell strain and application |
| CN108546706A (en) * | 2018-03-29 | 2018-09-18 | 杭州泰熙生物技术有限公司 | A kind of preparation of yellow fever virus recombinant antigen and its kit production method |
| CN108614117A (en) * | 2018-03-29 | 2018-10-02 | 杭州泰熙生物技术有限公司 | A kind of preparation of toxoplasma recombinant antigen, Toxophasma gondii detecting kit and preparation method thereof |
| US11167283B2 (en) | 2018-05-04 | 2021-11-09 | University Of South Carolina | Dot blot box and use thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007051271A2 (en) * | 2005-11-01 | 2007-05-10 | Fundacão Oswaldo Cruz - Fiocruz | Construction of recombinant adenovirus with genes that codify for sag1, sag2 and sag3 |
| CN102095862A (en) * | 2011-01-25 | 2011-06-15 | 厦门大学附属中山医院 | Immune imprinting kit for syphilis specificity IgM antibody and preparation method thereof |
| CN102095858A (en) * | 2011-01-25 | 2011-06-15 | 厦门大学附属中山医院 | Western blot kit for cardiolipin and specific IgM antibodies of syphilis and preparation thereof |
-
2011
- 2011-09-19 CN CN2011102793146A patent/CN102435732A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007051271A2 (en) * | 2005-11-01 | 2007-05-10 | Fundacão Oswaldo Cruz - Fiocruz | Construction of recombinant adenovirus with genes that codify for sag1, sag2 and sag3 |
| CN102095862A (en) * | 2011-01-25 | 2011-06-15 | 厦门大学附属中山医院 | Immune imprinting kit for syphilis specificity IgM antibody and preparation method thereof |
| CN102095858A (en) * | 2011-01-25 | 2011-06-15 | 厦门大学附属中山医院 | Western blot kit for cardiolipin and specific IgM antibodies of syphilis and preparation thereof |
Non-Patent Citations (4)
| Title |
|---|
| D. AUBERT, ET AL: "Recombinant Antigens To Detect Toxoplasma gondii-Specific Immunoglobulin G and Immunoglobulin M in Human Sera by Enzyme Immunoassay", 《JOURNAL OF CLINICAL MICROBIOLOGY 》, vol. 38, no. 3, 31 March 2000 (2000-03-31), pages 1144 - 1150 * |
| 杨培梁等: "弓形虫多表位基因重组抗原在弓形虫免疫检测中的应用", 《热带医学杂志》, vol. 07, no. 09, 28 September 2007 (2007-09-28), pages 855 * |
| 蒋守富等: "弓形虫抗体免疫印迹试剂盒的研制", 《中国寄生虫学与寄生虫病杂志》, vol. 23, no. 06, 30 December 2005 (2005-12-30) * |
| 谈永飞等: "应用重组抗原(rSAG1)检测IgM抗体诊断弓形虫病的研究", 《中国血吸虫病防治杂志》, vol. 16, no. 02, 15 April 2004 (2004-04-15), pages 133 - 136 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108546706A (en) * | 2018-03-29 | 2018-09-18 | 杭州泰熙生物技术有限公司 | A kind of preparation of yellow fever virus recombinant antigen and its kit production method |
| CN108614117A (en) * | 2018-03-29 | 2018-10-02 | 杭州泰熙生物技术有限公司 | A kind of preparation of toxoplasma recombinant antigen, Toxophasma gondii detecting kit and preparation method thereof |
| CN108330104A (en) * | 2018-03-30 | 2018-07-27 | 四川迈克生物新材料技术有限公司 | Anti-human IgM monoclonal antibody, its hybridoma cell strain and application |
| US11167283B2 (en) | 2018-05-04 | 2021-11-09 | University Of South Carolina | Dot blot box and use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104407137B (en) | A kind of CSFV velogen strain and low virulent strain differentiate Test paper | |
| CN104459144B (en) | A kind of PRV velogen strain and vaccine strain differentiate Test paper | |
| CN101825634A (en) | Reagent strip for joint detection of syphilis specific IgM and IgG antibodies and preparation method thereof | |
| CN106556701A (en) | Brucella melitensis indirect ELISA antibody assay kit | |
| CN102435732A (en) | Toxoplasma IgM antibody immunoblotting kit and preparation method thereof | |
| CN101858916A (en) | Reagent strip for testing syphilis specific IgM antibodies through gold immunochromatographic assay and preparation method thereof | |
| CN101592660A (en) | Brucellosis indirect enzyme-linked immunosorbent assay milk humoral antibody detection kit | |
| CN101858915A (en) | Reagent strip for testing syphilis specific IgG antibodies through gold immunochromatographic assay and preparation method thereof | |
| CN102288768A (en) | Toxoplasma gondii IgG (immunoglobulin G) antibody immunoblotting kit and preparation method thereof | |
| Sampaio et al. | Measles, rubella, mumps and Toxoplasma gondii antibodies in saliva of vaccinated students of schools and universities in São Paulo City, Brazil | |
| Schmidt et al. | Immunogenicity and antigenicity of human coronaviruses 229E and OC43 | |
| CN102435744A (en) | Colloidal gold immunochromatography assay reagent strip for total antibodies to Toxoplasma gondii and preparation method thereof | |
| CN202256346U (en) | Toxoplasma immunoglobulin M (IgM) antibody western blotting kit | |
| CN102095858A (en) | Western blot kit for cardiolipin and specific IgM antibodies of syphilis and preparation thereof | |
| CN202256347U (en) | Reagent strips for joint detection of toxoplasma immunoglobulin M (IgM) antibody and total antibody | |
| CN102360012A (en) | Immunochromatography detection reagent strip for combined detection of toxoplasmagondii IgG antibodies and total antibodies, and preparation method thereof | |
| CN201926664U (en) | Kit for immunoblot assay of specific IgG antibody against Treponema pallidum | |
| CN102305861B (en) | Reagent strip for carrying out joint detection on Toxoplasma gondii IgM (immunoglobulin M) and IgG (immunoglobulin G) antibodies and preparation method thereof | |
| CN202230087U (en) | Toxoplasma gondii total antibody immune imprinting kit | |
| CN202230085U (en) | Toxoplasma gondii immunoglobulin G (IgG) antibody immune imprinting kit | |
| CN102323420A (en) | The total antibody mediated immunity trace of arc worm kit and preparation method thereof | |
| Rosato et al. | Enzyme-linked immunosorbent assay detection of immunoglobulins G and M to Venezuelan equine encephalomyelitis virus in vaccinated and naturally infected humans | |
| CN102313811A (en) | Toxoplasma gondii IgG antibody colloidal gold immunity chromatography detection reagent strip and its preparation method | |
| CN201955343U (en) | Syphilis cardiolipin and specific antibody IgM western-blot kit | |
| CN201673158U (en) | Syphilis specificity IgG antibody collaurum immunity chromatographic detection test strip |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120502 |